Trial Profile
Evaluation of corneal damage after vitrectomy and effect of Rebamipide ocular solution
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 19 Dec 2014 New trial record